107 related articles for article (PubMed ID: 4040568)
1. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.
Cannon JG; Koble-Suarez C; Long JP; Ilhan M; Bhatnagar RK
J Pharm Sci; 1985 Jun; 74(6):672-5. PubMed ID: 4040568
[TBL] [Abstract][Full Text] [Related]
2. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
Wikström H; Sanchez D; Lindberg P; Arvidsson LE; Hacksell U; Johansson A; Nilsson JL; Hjorth S; Carlsson A
J Med Chem; 1982 Aug; 25(8):925-31. PubMed ID: 6811743
[TBL] [Abstract][Full Text] [Related]
3. p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects.
Cannon JG; Amoo VE; Long JP; Bhatnagar RK; Flynn JR
J Med Chem; 1986 Dec; 29(12):2529-34. PubMed ID: 3783613
[TBL] [Abstract][Full Text] [Related]
4. Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.
Cannon JG; Lee T; Goldman HD; Long JP; Flynn JR; Verimer T; Costall B; Naylor RJ
J Med Chem; 1980 Jan; 23(1):1-5. PubMed ID: 7188974
[TBL] [Abstract][Full Text] [Related]
5. Conformationally restricted congeners of dopamine derived from octahydrobenzo[g]quinoline and octahydrobenzo[f]quinoline.
Cannon JG; Hamer RL; Ilhan M; Bhatnagar RK; Long JP
J Med Chem; 1984 Feb; 27(2):190-5. PubMed ID: 6694167
[TBL] [Abstract][Full Text] [Related]
6. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
[TBL] [Abstract][Full Text] [Related]
7. II. Pharmacological studies with derivatives of 2-aminotetralin, benzhydro[f]quinoline, benzhydro[g]quinoline, apomorphine and clonidine suggest a pharmacological dissimilarity between peripheral presynaptic dopamine receptors and alpha-2 adrenoceptors.
Maixner W; Flynn JR; Arnerić SP; Cannon JG; Long JP
J Pharmacol Exp Ther; 1983 Feb; 224(2):352-8. PubMed ID: 6296357
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline.
Ilhan M; Long JP; Cannon JG
J Pharmacol Exp Ther; 1984 Nov; 231(2):361-6. PubMed ID: 6149308
[TBL] [Abstract][Full Text] [Related]
9. Structure activity relationships of resorcinol substituted ring systems.
Ilhan M; Long JP; Flynn J; Bhatnagar R; Cannon JG
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):22-32. PubMed ID: 6093720
[TBL] [Abstract][Full Text] [Related]
10. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
[TBL] [Abstract][Full Text] [Related]
11. Ha-117 and Ha-118 are potent dopamine receptor agonists.
Ilhan M; Long JP; Cannon JG
J Pharm Pharmacol; 1984 Mar; 36(3):213-4. PubMed ID: 6144764
[TBL] [Abstract][Full Text] [Related]
12. Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.
Cannon JG; Hatheway GJ
J Med Chem; 1976 Aug; 19(8):987-93. PubMed ID: 184283
[TBL] [Abstract][Full Text] [Related]
13. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
14. Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects.
Cannon JG; Suarez-Gutierrez C; Lee T; Long JP; Costall B; Fortune DH; Naylor RJ
J Med Chem; 1979 Apr; 22(4):341-7. PubMed ID: 571020
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
[TBL] [Abstract][Full Text] [Related]
16. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Hamblin MW; Creese I
Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs.
Verimer T; Long JP; Rusterholz DR; Flynn JR; Cannon JG; Lee T
Eur J Pharmacol; 1980 Jun; 64(4):271-7. PubMed ID: 7389823
[TBL] [Abstract][Full Text] [Related]
19. Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine.
Nordmann R; Petcher TJ
J Med Chem; 1985 Mar; 28(3):367-75. PubMed ID: 3973904
[TBL] [Abstract][Full Text] [Related]
20. On the preferred rotameric conformation for dopamine agonist action: an illusory quest.
Costall B; Lim SK; Naylor RJ; Cannon JG
J Pharm Pharmacol; 1982 Apr; 34(4):246-54. PubMed ID: 6124599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
